Dummer, Reinhard
Michielin, Olivier
Nägeli, Mirjam Chantal
Goldinger, Simone M.
Campigotto, Federico
Kriemler-Krahn, Ulrike
Schmid, Herbert
Pedroncelli, Alberto
Micaletto, Sara
Schadendorf, Dirk
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma
https://doi.org/10.1136/esmoopen-2018-000388
This article is maintained by: Elsevier
Article Title: Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma
Journal Title: ESMO Open
CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/esmoopen-2018-000388
Content Type: article
Copyright: © 2018 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ.